Ignite Creation Date:
2025-12-25 @ 2:29 AM
Ignite Modification Date:
2026-01-22 @ 6:15 AM
Study NCT ID:
NCT04153734
Status:
NOT_YET_RECRUITING
Last Update Posted:
2019-11-06
First Post:
2019-10-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC
Sponsor:
Kobe Minimally Invasive Cancer Center
Organization: